QuidelOrtho Corp (QDEL): Shareholders' Equity
$1.92B
As of 2025-12-28
$1.77B
As of 2026-06-28
-27.0%
3-year compound annual growth
+7.6%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $1.92B | -35.7% | 2026-02-19, Balance as of period end |
| 2024-12-29 | $2.98B | -40.4% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $5.01B | +1.4% | 2026-02-19, Balance as of period end |
| 2023-01-01, Fiscal 2022 | $4.93B | +155.8% | 2025-02-27, Balance as of period end |
| 2022-01-02, Fiscal 2021 | $1.93B | +44.8% | 2024-08-01, Balance as of period end |
| 2021-01-03, Fiscal 2020 | $1.33B | n/a | 2023-02-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $1.92B | -35.7% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.61B | +0.6% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $1.09B | +0.2% |
| Neogen Corp (NEOG) | 2026-05-31 | $2.09B | +1.0% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $368.00M | -47.5% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
Compare QDEL, IDXX, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗